Atrás
Rango del Día
$16.43
$16.43
Rango de 52 Semanas
$11.16
$17.54
Volumen
100
Promedio 50D / 200D
$16.37
/
$14.41
Cierre Anterior
$16.43
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 36.7 | 0.4 |
| P/B | 2.3 | 2.9 |
| ROE % | 7.4 | 3.8 |
| Net Margin % | 4.4 | 3.9 |
| Rev Growth 5Y % | 10.7 | 10.0 |
| D/E | 2.0 | 0.2 |
Puntos Clave
Revenue grew 10.71% annually over 5 years — strong growth
Earnings grew 15.85% over the past year
Negative free cash flow of -42.83M
P/E of 36.70 — premium valuation
ROIC of 3.40% — low return on invested capital
Crecimiento
Revenue Growth (5Y)
10.71%
Revenue (1Y)12.42%
Earnings (1Y)15.85%
FCF Growth (3Y)N/A
Calidad
Return on Equity
7.42%
ROIC3.40%
Net Margin4.43%
Op. Margin9.68%
Seguridad
Debt / Equity
1.99
Current Ratio0.51
Interest Coverage2.15
Valoración
P/E Ratio
36.70
P/B Ratio2.27
EV/EBITDA30.25
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12.42% | Revenue Growth (3Y) | 13.07% |
| Earnings Growth (1Y) | 15.85% | Earnings Growth (3Y) | 151.43% |
| Revenue Growth (5Y) | 10.71% | Earnings Growth (5Y) | 21.16% |
| Profitability | |||
| Revenue (TTM) | 1.00B | Net Income (TTM) | 44.49M |
| ROE | 7.42% | ROA | 1.76% |
| Gross Margin | 13.97% | Operating Margin | 9.68% |
| Net Margin | 4.43% | Free Cash Flow (TTM) | -42.83M |
| ROIC | 3.40% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.99 | Current Ratio | 0.51 |
| Interest Coverage | 2.15 | Dividend Yield | 0.04% |
| Valuation | |||
| P/E Ratio | 36.70 | P/B Ratio | 2.27 |
| P/S Ratio | 1.63 | PEG Ratio | -4.48 |
| EV/EBITDA | 30.25 | Dividend Yield | 0.04% |
| Market Cap | 1.63B | Enterprise Value | 2.94B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.00B | 893.16M | 785.37M | 718.59M | 668.49M |
| Net Income | 44.49M | 38.40M | 7.04M | 10.67M | 20.65M |
| EPS (Diluted) | 0.48 | 0.53 | 0.10 | 0.15 | 0.31 |
| Gross Profit | 140.24M | 893.16M | 146.31M | 91.00M | 81.85M |
| Operating Income | 97.24M | 103.19M | 115.40M | 38.04M | 56.83M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.53B | 1.86B | 1.70B | 1.68B | 1.61B |
| Total Liabilities | 1.82B | 1.38B | 1.32B | 1.25B | 1.20B |
| Shareholders' Equity | 718.94M | 480.72M | 373.77M | 434.69M | 405.85M |
| Total Debt | 1.43B | 1.01B | 1.01B | 977.96M | 950.28M |
| Cash & Equivalents | 119.56M | 127.20M | 24.40M | 38.05M | 29.05M |
| Current Assets | 177.73M | 164.87M | 60.70M | 83.76M | 95.74M |
| Current Liabilities | 351.15M | 388.11M | 508.46M | 336.71M | 230.47M |